Kexin has over four years of research experience in regenerative medicine, molecular biology, and EV-based therapeutics. Her MPhil project focused on the osteogenic potential of osteoblast-derived EVs using 3D bioprinting and mesenchymal stromal cells. She has expertise in EV isolation and uptake assays, RNA extraction, qPCR, ELISA, Western blotting, confocal microscopy, Micro-CT imaging, and in vivo rodent handling. Her work bridges clinical and laboratory settings with a focus on translational research